The Effect of Rapamycin on Cardiac Allograft Vasculopathy in Rats

HU Ming-song,HU Jian-guo,ZHENG Bao-shi
2010-01-01
Abstract:Objective To investigate the role of rapamycin in the prevention of cardiac allograft vasculopathy in rats. Methods Heterotopic heart transplantation models were established.Hearts from wistar rats were heterotopically transplanted to SD rats(allograft) or wistar rats(isograft).They were randomly divided into rapamycin-treated group(rapamycin,1.25 mg/(kg·d),administration by oral intubation after cardiac transplantation),Cyclosporine A-treated group(Cyclosporine A,10 mg/(kg·d),administration by oral intubation),and isograft group,no immunosuppressant.All of the animals were killed at 90 days after transplantation.Normal hearts of wistar rats served as controls.The paraffin sections of cardiac allograft were stained by hematoxylin and eosin,Van Gieson to detect the inflammatory cell infiltration and graft arteriosclerosis. Results Normal hearts and isografts have no cellular infiltration and the vascular intimal thickness were lower than those in the allografts.Compared with Cyclosporine treated allografts,the vessel disease in Rapamycin treated allografts decreased significantly 90 days after transplantation(P<0.01). Conclusions Rapamycin may halt the progression of cardiac allograft vasculopathy in rats.
What problem does this paper attempt to address?